Testing intensity is part of the story in gonorrhoea and chlamydia burden

Clinical Microbiology and Infection · Published 2026-07-01 · DOI 10.1016/j.cmi.2026.07.039

Authors (3)

Angelo Roberto Raccagni, Tommaso Clemente, Silvia Nozza

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Raccagni, A., Clemente, T., Nozza, S. (2026). Testing intensity is part of the story in gonorrhoea and chlamydia burden. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2026.07.039

Related articles

• Added value of point-of-care testing for Group A Streptococcus in community pharmacy sore throat pathways: analysis of the Wales Sore Throat Test and Treat service · Clinical Microbiology and Infection · 2026 · Same journal
• Concordance between nasopharyngeal swab and bronchoalveolar lavage PCR for respiratory viruses · Clinical Microbiology and Infection · 2026 · Same journal
• “Beyond Clinical Prediction Rules: What a Large Community Pharmacy Study Reveals About Point-of-Care Testing for Group A Streptococcus.” · Clinical Microbiology and Infection · 2026 · Same journal
• Reference-standard agreement versus clinical appropriateness: rethinking LLM evaluation in infectious diseases and clinical microbiology · Clinical Microbiology and Infection · 2026 · Same journal
• Assessment of Timing for Influenza Vaccination among Older Adults in Japan: The VENUS Study · Clinical Microbiology and Infection · 2026 · Same journal
• Transmission Pathways in Emerging Infections: Linking Clinical Presentation, Epidemiology, and Outbreak Potential in Humans · Clinical Microbiology and Infection · 2026 · Same journal
• Pneumococcal disease outbreaks in sub-Saharan Africa: rethinking the paradigm in disease control · Clinical Microbiology and Infection · 2026 · Same journal
• Transport delay of patient specimens undermines tuberculosis drug-resistance diagnostics: programmatic experience from a high-burden setting · Clinical Microbiology and Infection · 2026 · Same journal
• Optimizing dalbavancin dosing for complicated methicillin-resistant Staphylococcus aureus infections: a multicentre population pharmacokinetic study · Clinical Microbiology and Infection · 2026 · Same journal
• Efficacy and safety of a radiographic severity-stratified all-oral short treatment regimen for multidrug/rifampicin-resistant tuberculosis in China: an open-label, multicentre, randomised controlled, noninferiority trial · Clinical Microbiology and Infection · 2026 · Same journal